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Abstract: The article presents findings of research on e‑health development in four European Un‑
ion (EU) Member States in the context of public procurement of innovation (PPI). EU policies attempt 
to make public procurement leverage for innovation by introducing a number of new tender proce‑
dures. Policies and practices in PPI, including e‑health, were investigated for Denmark, Great Britain, 
Spain and Poland. For various reasons, all four countries struggle with the introduction of the Euro‑
pean PPI procedures, and with making a transition to outcome‑based tenders. Though they all intro‑
duced policies implementing these procedures, Denmark and Great Britain seem to have achieved 
better results, having well‑established public‑private collaboration. This correlates with a more effi‑
cient adoption of e‑health solutions in those countries. With some minor successes, Spain, and par‑
ticularly Poland, display attachment to traditional procedures despite changes in the public procure‑
ment regulations.
Keywords: e‑health, public procurement, innovation, European Union
JEL: I18, I19, H57, O38, N44
FOE 4(337) 2018 www.czasopisma.uni.lodz.pl/foe/
220 Marcin Kautsch, Mateusz Lichoń, Natalia Matuszak
1. Introduction
Public health care sector faces a number of challenges, many of which are expect‑
ed to intensify in the future. Ageing of the population, growing burden of chron‑
ic diseases and shrinking tax base are good examples of such challenges (Knuts‑
son, Thomasson, 2014: 242–255). Health care systems are in particular need for 
innovation necessary to overcome these issues. Information and communications 
technologies (ICT) hold much promise in providing solutions capable of increas‑
ing efficiency in health care delivery and data management (European Commis‑
sion, 2004).
There is, however, a considerable difference in implementation of these prom‑
ising solutions across European countries. Despite a relatively recent introduction 
of ICT solutions in health care, studies suggest that some countries may already 
be considered frontrunners (e.g. Denmark, UK), leapfroggers (e.g. Spain) and lag‑
gards (e.g. Poland) (Currie, Seddon, 2014). That suggests important systemic dif‑
ferences in the approach to innovation between various countries. This article 
aims to assess the scope of such differences in relation to the role of innovations 
in procurement by analyzing barriers and opportunities for developing e‑health 
and innovative procurement.
2. Public procurement of innovation
Many definitions of public procurement can be found. The basic ones refer to the 
process by which public authorities purchase work, goods or services (European 
Commission, n.d.). As far as innovation is concerned, in this paper, it will be un‑
derstood as “the process of making changes to something established, by introduc‑
ing something new that adds value to customers and contributes to the knowledge 
store of the organization” (O’Sullivan, Dooley, 2008: 5).
PPI1 is sometimes defined as procurement of something that does not yet exist 
(Uyarra, Flanagan, 2010: 123–143). However, as some authors (Rolfstam, Phillips, 
Bakker, 2011: 452–468; Greenhalgh et al., 2004: 581–629) point out, what is a reg‑
ular, off the shelf product or service in one society, can easily be considered an in‑
novation somewhere else.
1 Also referred to as Public Procurement of Innovative Solutions, Public Innovation Procure‑
ment and Innovative Public Procurement. Similar, although a narrower concept, is public technol‑
ogy procurement or government technology procurement. For more, see: Rolfstam (2008).
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2.1. General barriers to and opportunities for public procurement 
of innovation
Amann and Essig (2015: 3) point out that “public procurement goals such as cost ef‑
ficiency, legal conformity as well as the advancement of environmental protection, 
and the promotion of innovation often represent competing priorities”. PPI is also 
time‑consuming as a result of the requirement of coordination between many stake‑
holders, not to mention navigating through the unknown process without well‑es‑
tablished routines. Risk aversion characterising public officials responsible for pro‑
curement is perhaps the barrier most often cited in the subject literature. Greenhalgh 
et al. (2004: 597) recall multiple studies suggesting that if an innovation is per‑
ceived as risky to an individual making a choice about its adoption, it is less likely 
to be adopted. According to Kalvet and Lember (2012: 241–262), risk management 
practices constitute another important barrier; naturally risk‑averse, public contrac‑
tors try to shift risks back to suppliers, or to third‑party institutions when possi‑
ble. According to the authors, mainstreaming PPI may require further innovations 
in the process of procurement itself, in order to make it easier to manage risks bigger 
than those involved in procurement of ready‑made services and products. Never‑
theless, Amann & Essig (2015: 1–11) suggest that risk aversion may not be the main 
factor contributing to the unpopularity of PPI; instead, aversion to complexity plays 
the biggest role, with time limitation being the second most significant barrier.
Despite the fact that new instruments (see below) were introduced in the EU with 
the purpose of making PPI easier, the accompanying legal regulations are perceived 
as complicated, which discourages potential suppliers from participation (especially 
SMEs). This perception holds back contracting institutions as well; fearing appeals 
from the tender results, they “play it safe” (Knutsson, Thomasson, 2014: 242–255).
Innovative products, services or processes require some prerequisites (Galanes, Ad‑
ams, 2006; Caldwell, O’Reilly III, 2003: 497–517) to be developed. Those include sup‑
port for risk‑taking and tolerance for mistakes (Bain, Mann, Pirola‑Merlo, 2001: 55–73). 
Various studies (Knutsson, Thomasson, 2014: 242–255; Dale‑Clough, 2015: 1–23) sug‑
gest that the power of local authorities in triggering and deploying innovative solutions 
may prove greater than expected, provided they learn from each other’s experiences 
and adapt their tender guidelines accordingly. Best results are achieved where institu‑
tionalised collaboration between authorities, R&D and businesses is established.
2.2. E-health: definition and relation to PPI
Definition of e‑health used by the European Commission (EC) is very broad; it en‑
compasses most of the health care tasks executed via ICT. According to the EC, 
e‑health “means ICT tools and services for health. E‑health covers the interaction 
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between patients and health service providers, institution‑to‑institution transmis‑
sion of data, or peer‑to‑peer communication between patients and/or health pro‑
fessionals” (European Commission, 2011: 4).
E‑health solutions have been playing an increasingly important role in health 
care systems across the world (Iakovidis, Wilson, Healy, 2004) and its development 
is recommended by the World Health Organization (World Health Organization, 
2005). In the EU alone, e‑health market was estimated at €21 billion in 2006 (Do‑
brev et al., 2010). In 2016, in the European OECD countries, public expenditure was 
75.1% of total health care expenditure (OECD, 2017), which shows how important 
the role of the states is in creating the e‑health sector. ICT solutions in health care 
have been intensely promoted by the European Commission (2013; 2014a) in a be‑
lief that ICT can help the EU in dealing with a growing burden of chronic diseases, 
and reduce care and treatment costs (Bell, Thornton, 2011: 51–56; Kumar, Bauer, 
2011: 119–131). Because many e‑health services are created from scratch and first 
of their kind, at least in their local contexts, they are innovative by nature.
3. Research methods
Desktop study research conducted between February and May 2015, included 
a secondary analysis of documents regarding innovation procurement and e‑health. 
Its aim was to identify and compare the various approaches to PPI and e‑health, un‑
derstand definitions used in national documents, regulations regarding those issues 
and plans for future development. The analysis also included aims, strategies, key 
public bodies and time frames. During the preparatory phase of the desktop study, 
a questionnaire consisting of 15 elements corresponding with the above‑mentioned 
issues was developed and later used in case of all analyzed countries to secure con‑
sistency and comparability of the results.
4. PPI in the policies of the European Union and 
selected Member States
Responsible for about 19.4% of GDP in the 27 EU Member States (data from 2009) 
(Amann, Essig, 2015: 1–11), public procurement is perceived by the EU as a pow‑
erful tool for reaching goals like employment, environmental protection, social 
equality and technological development. Prior to the formulation of the Lisbon 
Strategy in 2000, EU policies on public procurement were strongly influenced 
by neo‑liberal school of economics. Factors like cost efficiency and freeing com‑
mon European market from national protections had been prioritized (Rolfstam, 
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2009: 349–360). However, the millennium shift set a new vision of the EU as the 
most competitive and knowledge‑based economy in the world. Reaching this vi‑
sion required a strong stimulus. To facilitate public procurement of innovation, 
new procurement procedures were introduced, promoting practices that previous‑
ly would have invalidated tender on legal grounds:
1. Competitive dialogue, derived from the Directive 2004/18/EC European Com‑
mission 2005, later replaced by the Directive 2014/24/EU. It involves several 
rounds of discussions between the contractor and potential suppliers, shifting 
focus from the input demanded from suppliers to the outcome desired by the 
contractor (Hoezen, Voordijk, Dewulf, 2012: 145–158), and making room for 
innovative solutions to be presented.
2. Technical dialogue is regulated by the EC directives 2014/24/EU and 2014/25/
EU. It allows a procurer to request a consultation or relevant information 
(not necessarily technological in nature) before starting tendering process, 
in order to specify requirements of the solution (UZP, 2014). It is deemed in‑
novation‑friendly because it increases the odds that contracting authority be‑
comes aware of previously unknown solutions.
3. Pre‑commercial procurement (PCP) is described as procurement of research 
and development of solutions before they are commercially developed, with 
“different suppliers competing through different phases of development. The 
risks and benefits are shared between the procurers and the suppliers under 
market conditions” (European Commission, 2015; Edquist, Zabala‑Iturria‑
gagoitia, 2015: 147–160).
4. Innovation partnership procedure derives from the Directive 2014/24/EU that 
repealed Directive 2004/18/EC. It enables a procurer to enter with a supplier 
or suppliers into a structured partnership that would proceed in stages, with 
intermediate targets.
The EC is firmly committed to its PPI strategy, despite difficulties with the adop‑
tion of this systemic change. The literature on the topic points to organisational resist‑
ance to transition from specification‑based tenders to outcome‑based tenders (Uyarra 
et al., 2014: 631–645). Part of this resistance comes from the fact that the new proce‑
dures involve practices (meetings with potential suppliers, negotiable nature of the 
solution) that go against safeguards of fairness in the tender process. Once the price 
ceased to be the deciding factor, procurement process may have become morally and 
legally confusing for some procurers. The EU, by asking the Member States to widely 
adopt the PPI procedures, actually asks them to change organisational cultures in their 
public institutions, to further correspond with the legal frameworks for procurement. 
The PPI requires more coordination among stakeholders (Amann, Essig, 2015) than 
regular procedures, which are already complex. Individual Member States approach 
it very differently; some had made it part of their policy even before the EU did, while 
others restrict themselves to formal compliance with the EU requirements.
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4.1. Legal barriers to PPI
The authors in their previous work (Kautsch, Lichoń, Matuszak, 2016) explored 
in detail the legal obstacles that various ICT technologies encountered when enter‑
ing the health care systems in various EU states, and how e‑health, in fact, prompt‑
ed a re‑think and updates of the law. Main areas of concern were: professional re‑
sponsibility during remote medical consultations, protection of the personal data 
from unauthorised access and secondary (e.g. research) uses of personal health 
data with associated questions of patient’s consent, as well as responsibility for 
ensuring systems interoperability.
Legal and technical complications related to the above problems halted devel‑
opment of e‑health for a long time.
During PPI procedures, concerns regarding the lawfulness of the solutions pro‑
cured are compounded by concerns related to the procurement process itself.
4.2. PPI in Denmark
There is no national initiative promoting PPI in the area of e‑health solutions 
in Denmark, which can be explained – to a certain extent – by strong decentral‑
isation of the Danish health care system. Nevertheless, the Association of Lo‑
cal Governments, Association of Danish Regions, and the Government published 
in 2012 a National Action Plan for Dissemination of Telemedicine (Digitaliser‑
ingsstyrelsen, 2014) and, in 2013, Strategy for Digital Welfare 2013–2020 (Danish 
Government et al., 2013) on dissemination of telemedicine throughout the country. 
The government has committed itself to PPI through the Strategy for Intelligent 
Public Procurement, the establishment of the Market Development Fund and the 
Bill for Public Tendering.
What is more, representatives of the public sector and the industry form the 
Committee for Medical Equipment (Sundhedsstyrelsen, 2015) that advises the Min‑
ister for Health and Prevention in maintaining an overview over initiatives within the 
field of medical equipment, including e‑health solutions. Table 1 gives an overview 
of barriers to PPI that exist in Denmark, along with opportunities created for it.
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Table 1. Barriers to and opportunities for PPI in Denmark
Barriers Opportunities
1. Competitive dialogue use 
stopped by national Appeal 
Board for Public Tenders’ ruling.
2. Need for solutions that have 
proved to be reliable and are 
offered at reasonable prices.
3. Traditionally very detailed re‑
quirements’ specifications that 
offer little incentive or opportu‑
nity for suppliers to offer some‑
thing different.
4. Perception of innovative pro‑
curement procedures as costlier 
rather than typical ones.
1. Grants from Market Development Fund for contracting 
authorities using pre‑competitive procurement, at least 
for the 2014–2016 period.
2. Increasing use of outcome‑based specifications.
3. Institutional support for collaboration between science 
and SMEs.
4. Promotion of “industrial PhD”, where a PhD candidate 
conducts research funded by a private company inter‑
ested in commercialization of the results
5. “Innovation vouchers” for companies investing for the 
first time in innovative solutions.
6. Government’s investment in the R&D. Private sector’s 
investment in the R&D at the level of 70%.
7. Commitment to studying innovation procurement 
as an organisational process, which makes it possible 
to remove barriers to innovation that stem from human 
behaviour.
Source: Adamiec (2011: 133–156), Markedsmodningsfonden (2014); Seemann, Dinesen, Gustafsson (2013: 1–18)
4.3. PPI in Great Britain
There are strong ties between science and business in Great Britain. They are cou‑
pled with government’s support for the cooperation with the scientific community 
(Adamiec, 2011: 133–156). No PPI strategy for e‑health that would apply across 
whole Great Britain was defined, though national branches of National Health Ser‑
vice (NHS) expressed an intention to engage in innovation procurement. There 
are various institutions (centres, committees, groups etc.)2 established specifical‑
ly with the purpose of stimulating PPI, with PCP being the procedure of choice. 
NHSs define their own strategies, and then implement them through specific rec‑
ommendations, for instance, English National Innovation Procurement Plan from 
2009 (Department of Health, 2009) or Scottish Route Map to the 2020 Vision for 
Health and Social Care (Scottish Government, 2013) and National Telehealth and 
Telecare Delivery Plan to 2015 (Scottish Government, 2012). The official strategy 
encourages authorities to take innovation criterion into account when tendering, 
but austerity measures slowed down transition towards new procurement proce‑
dures. According to Dale‑Clough (2015: 1): “In the aftermath of the 2008 global 
financial crisis, and resultant changes to public sector funding, national procure‑
2 E.g. Government Chief Science Adviser, Technology Strategy Board, National Innovation 
Fund, NHS National Innovation Centre and nine regional ones, Support Commissioning Units, 
Technology Enabled Care Services Resource for Commissioners, etc.
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ment policy in some settings shows signs of a retreat to efficiency savings and cost 
reduction as key performance indicators.”
Researching outcomes of PPI may substantially help overcome barriers re‑
lated to lack of proof of efficiency. Studying organisational dimension is neces‑
sary to deal with some “human factor” obstacles. Some of the significant barriers 
to implementation of PPI tools are presented below in Table 2, along with factors 
supporting it.
Table 2. Barriers to and opportunities for PPI in Great Britain
Barriers Opportunities
1. Lack of engagement between
procurers and suppliers.
2. Overly prescriptive and
burdensome procurement
processes.
3. Risk aversion and insufficient
procurement capability.
4. Failure to identify unmet needs
before they become too urgent
for PPI process to be initiated.
5. Lack of know‑how among
supply‑chain managers.
6. Prevalence of solution‑led rather
than outcome‑led specifications.
1. The legal duty of strategic health agencies to promote
innovation.
2. Strong representation of science community in the form
of Government Chief Science Adviser who cooperates
with the Prime Minister directly.
3. Strong cooperation between science and business
(Technology Strategy Board).
4. Efficiency in gaining EU grants and financing for
R&D. Tax breaks for SME’s engaging in R&D. Promo‑
tion of health care and business cooperation for innova‑
tion, e.g. Scottish Health Innovation Assessment Portal
(HIAP‑Scotland) encouraging innovators and providing
them with a feedback.
5. Presence of specialised bodies within the NHS’s
dedicated to promotion and improvement of PPI 
and/or e‑health.
6. National £220 million Innovation Fund for health
authorities.
7. A developed system of institutions implementing PPI
strategy. In England alone, there is an NHS National
Innovation Centre and nine regional ones. They
cooperate with Support Commissioning Units.
8. Introduction of Technology Enabled Care Services
(TECS) Resource for Commissioners – a set of tools 
facilitating commissioning of e‑health solutions.
Source: Adamiec 2011, 133–156; Common Services Agency for the Scottish Health Service, 2013; Department 
for Business Innovation & Skills, 2011; Department of Health, 2009; House of Lord’s Science and Technology 
Committee, 2011; NHS Commissioning Assembly, 2015; Office of Government Commerce, 2004
4.4. PPI in Poland
In 2010, the Public Procurement Office joined Polish Agency for Enterprise Devel‑
opment in an initiative called New Approach to Public Procurement (Nowe podejś‑
cie do zamówień publicznych), which involved publication of guidelines informing 
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about new priorities in public procurement and new methods of conducting tenders 
(UZP, 2011). It was accompanied by conferences and training for public procurers 
(Wiktorowicz, 2011). The main goal was to improve the odds of micro‑, small and 
medium enterprises in public tenders, through raising officials’ awareness of the 
benefits and innovations that they can bring. So far (May 2017), the direction to‑
wards which PPI is heading remains uncertain. While social and environmental 
clauses slowly become popular (Joniewicz, Jawor‑Joniewicz, 2015), PPI examples 
can be rarely found. With the implementation of the Directive 2014/24/EU, which 
was due in April 2016 and finally introduced in June 2016, there are still contro‑
versies over a shape of the bill that is supposed to introduce it (Borowska, 2015; 
Wikariak, 2015).
Table 3. Barriers to and opportunities for PPI in Poland
Barriers Opportunities
1. Low general awareness.
2. Lack of experience in PPI among both 
procurers and suppliers.
3. Prevalence of short‑term, small‑scale 
procurement strategies.
4. Difficulties on the side of procurers 
in defining features, conditions and criteria 
of choice of a desired solution.
5. Risk aversion aggravated by stiff 
bureaucratic procedures.
6. Over‑reliance on the criterion of price 
as a “safe” one.
7. Conservative and risk‑averse culture 
of majority of public institutions (also the 
auditing ones).
8. Lack of active support from public 
or political institutions.
1. Amendments to Public Procurement Law:
2. June 2016: further adjustment of the Polish 
regulations to the EU ones.
3. August 2014: limiting phenomena 
of offering abnormally low prices, making 
price the only criterion, and keeping too 
much information classified as a business 
secret.
4. October 2012: introducing technical 
dialogue.
5. Growing public interest in social 
and environmental clauses in public 
procurement (signals a rising awareness 
of its role in the economy).
Source: Enterprise Europe Network, 2013; Wiktorowicz, 2011; Sejm Rzeczypospolitej Polskiej, 2012; 2014; 2016; 
Smart‑Grids.pl, 2014
Strategies for innovative economy and e‑health seem to be largely separate 
in practice; currently the Ministry of Health and CSIOZ (Centrum Systemów In‑
formacyjnych Ochrony Zdrowia, Centre of Health Information Systems, a Minis‑
try of Health agency), an institution responsible for digitalisation of Polish health 
care system, fail to meet deadlines and struggle with implementation of medical 
data exchange systems (some of which may be considered innovative on the Pol‑
ish market) and computerisation of health care facilities.
Despite some positive changes in the country’s policies that led to the wid‑
er inclusion of criteria other than purchase price in tenders (Wiktorowicz, 2011), 
in practice it is still the price that is the deciding factor, with an average weight 
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of 90% (UZP, 2015). Technical dialogue was used only in 0.19% of public tenders 
(UZP, 2013), competitive dialogues are practically non‑existent.
However, it is too early to assess the influence of those amendments on the pro‑
curement practices in Poland. The direction of changes and involvement of legis‑
lative authorities create an opportunity for the development of PPI in the country 
(Kautsch, Lichoń, Whyles, 2015: 312–323). Table 3 presents barriers to and oppor‑
tunities for PPI introduction in Poland.
4.5. PPI in Spain
The National Innovation Strategy (Estrategia Estatal de Innovación, e2i) (Minis‑
terio de Economía y Competitividad, 2012) is incorporated in the Law of Science, 
Technology and Innovation (Jefatura del Estado, 2011) that introduces policy in‑
struments such as PPI, territorial cooperation and internationalization as means 
to the end of transforming Spain into a knowledge‑based economy. Research, de‑
velopment and innovation are treated as inseparable parts of the process.
There is no nation‑wide PPI strategy concentrating on e‑health. Nevertheless, 
the regional governments do procure innovation for health care, e.g. Galicia led 
two PPI projects: Hospital2050 and InnovaSaúde (European Commission, 2014b; 
Consellería de Sanidade e o Servizo Galego de Saúde, n.d.). InnovaSaúde focused 
on digitalisation and mobile health care services. Hospital2050 involved procure‑
ment of technologies helping to create an energy self‑sufficient hospital and in‑
troduce innovative management technologies. Innovative procurement tools were 
used in both projects. In Table 4 below barriers to and opportunities for PPI de‑
velopment in Spain are presented.
Table 4. Barriers to and opportunities for PPI in Spain
Barriers Opportunities
1. Unconcern of the R&D sector with 
commercialization.
2. Aversion to risk of both suppliers and 
procurers, coupled with a tendency 
to bureaucratic inertia.
3. Perception of PPI as more expensive and 
time‑consuming.
4. Budget deficits aggravating aversion 
to investing in untested solutions with 
an uncertain price.
1. Central and regional governments’ support 
for PPI.
2. Best Practice Guides providing “tender 
templates” distributed by the Ministry 
of Economy and Competitiveness.
3. Studies on the PPI taking into account 
“human factor”.
Source: Castells et al., 2007; Luis, Alvarez De Sotomayor, Garrido, 2013; Roig, Saigí, 2011: 397–402;  
Ministerio de Economía y Competitividad, 2012
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5. Conclusions
Variety of barriers and challenges that particular countries need to face regard‑
ing e‑health and innovation emphasise their varying levels of development and 
different organisational cultures. In the case of the countries that are more ad‑
vanced in using PPI (Denmark, Great Britain) also more opportunities in devel‑
oping e‑health were identified. Poland and Spain having less experience in these 
areas seem to perceive the mentioned development through the perspective of bar‑
riers mostly.
Not surprisingly, risk aversion, existing, complicated procedures and lack 
of belief in novelty or a belief that the innovation has to be more expensive than 
the existing solutions are barriers common to all states. In all of them, the central/
local government’s help (existing or expected) is seen as an obvious opportuni‑
ty, which shows how important this factor is, though it can be described as a pre‑
requisite. While Poland and Spain have great expectations in such governmental 
incentives, Denmark and Great Britain seem to be utilizing government support 
(issued legal acts) and both are far more pro‑active in seeking other opportunities. 
Maybe Poland/Spain due to the reasons presented above do not have structures, 
but expectations?
Knutsson & Thomasson (2014: 242–255) point out to the importance of lo‑
cal authorities in the process of developing innovative solutions, driving changes 
in their local markets. Research suggests that coherence of goals among different 
levels of management is crucial for successful adoption of innovation (Greenhal‑
gh et al., 2004: 581–629). For this reason, determination of an official procurement 
strategy that sets and aligns goals may prove an important step towards populari‑
sation of PPI. Ideally, PPI policies should be coherent on different levels of author‑
ity: from central government to municipalities.
Great Britain and Denmark, both highly innovative economies, differ in terms 
of governmental involvement, financing and reception of the innovative procure‑
ment tools, as well as in the roles that local authorities play in the health care ser‑
vice. Their common feature is a well‑functioning and institutionalised coopera‑
tion between science, business and public institutions, such as health care funds 
or regional governments. This kind of institutional cooperation seems to constitute 
a strong incentive for PPI to develop, especially in the field of e‑health. British and 
Danish trials of e‑health suggest that studying both technical efficiency of solutions 
and organisational dimension of PPI help improve the processes. While Denmark 
seems to have largely overcome legal obstacles to the new mode of conducting ten‑
ders, Poland struggles with the implementation of PPI legislation and is attached 
to almost solely price‑based forms of procurement. Major problems in Spain seem 
to result rather from bureaucracy and severe budget cuts than from the law. Simi‑
larly to Poland, Spain cannot boast strong cooperation between science and busi‑
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ness. The low propensity for inter‑institutional collaboration may be the main rea‑
son behind the relative lack of innovativeness.
In their comprehensive review of the literature on dissemination of innovation, 
Greenhalgh et al. (2004) enumerate attributes that a service organisation should 
have if it is to successfully reutilise innovation adoption. Large size, maturity, de‑
centralised decision‑making structure, good internal communication and positive 
managerial attitudes were mentioned, among others. A rather obvious conclusion 
might be that PPI will be most readily adopted in institutions that are already in‑
novating. The results of the research conducted by the authors show, which is not 
surprising, that organisational culture within health care system may be a strong‑
er predictor of PPI success than the formal implementation of EU directives or in‑
troduction of PPI procedures.
In order to fully exploit the potential of PPI, health care managers might have 
to address organizational patterns that stand in the way of embracing innovation. 
Governmental support, tangible evidence and widespread awareness are necessary 
to achieve it. Without these prerequisites, ambitious European plans will be at risk 
of remaining a set of cumbersome procedures with nebulous goals.
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Prawo dotyczące innowacyjnych zamówień publicznych i rozwój e‑zdrowia w państwach 
członkowskich UE. Czego można się nauczyć?
Streszczenie: W artykule przedstawiono wyniki badań nad e‑zdrowiem w czterech państwach Unii 
Europejskiej (UE) omówione przez pryzmat innowacyjnych zamówień publicznych (PPI). Polityka UE 
stara się uczynić zamówienia publiczne dźwignią innowacji, wprowadzając szereg nowych procedur 
przetargowych. Zbadano zasady i praktyki w zakresie PPI, w tym w e‑zdrowiu, w Danii, Wielkiej Brytanii, 
Hiszpanii i Polsce. Z różnych powodów wszystkie cztery kraje zmagają się z wprowadzeniem nowych 
europejskich procedur PPI oraz przejściem na przetargi oparte o efekty, które przyniosą stosowane 
dobra czy usługi. Choć wszystkie kraje wprowadziły ustawodawstwo umożliwiające takie procedu‑
ry, Dania i Wielka Brytania wydają się osiągać lepsze rezultaty, mając ugruntowane zaangażowanie 
na rzecz współpracy publiczno‑prywatnej w celu włączania przedsiębiorstw w zamówienia publiczne 
nakierowane na innowacje. Wydaje się to korelować z bardziej wydajnym wdrożeniem rozwiązania 
e‑zdrowia w tych krajach. Mimo pewnych sukcesów w omawianej dziedzinie oraz zmian w prawie 
zamówień publicznych Hiszpania i Polska wykazują przywiązanie do tradycyjnych procedur.
Słowa kluczowe: e‑zdrowie, zamówienia publiczne, innowacje, Unia Europejska
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